Health Technology Assessment is now relatively settled and developed the methodology. It is a multidisciplinary discipline HTA (Health Technology Assessment) that evaluates medical, economic, social and ethical aspects of the introduction of new technologies, eg.
Pharmaceuticals, therapeutic, diagnostic and preventive procedures into practice. Retrospective evaluation of cost effectiveness was conducted from the perspective of health care providers.
We worked with the method of cost-effectiveness (CEA), the ratio of incremental costs and effects (ICER) and the cost-benefit analysis (CUA).